Inactivated smallpox vaccine: immunogenicity of inactivated intracellular and extracellular vaccinia virus.
about
Poxvirus pathogenesisEnvelope formation is blocked by mutation of a sequence related to the HKD phospholipid metabolism motif in the vaccinia virus F13L proteinThe envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence.Immune response in rabbits to surface components of extracellular and intracellular forms of vaccinia virus.Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.Characterization of intracellular and extracellular vaccinia virus variants: N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release.Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virus.Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus.Extracellular vaccinia virus envelope glycoprotein encoded by the A33R geneA novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors.Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection modelB5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals.The immune response to infection with vaccinia virus in mice. I. Infection and the production of antibody neutralizing cell-associated and cell-free virusExtracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope.The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccinationDeletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope.Role of cell-associated enveloped vaccinia virus in cell-to-cell spreadExtracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge.Localization and fine structure of a vaccinia virus gene encoding an envelope antigenVaccinia virus entry/fusion complex subunit A28 is a target of neutralizing and protective antibodiesProtective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions.The strategic use of novel smallpox vaccines in the post-eradication world.Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon.Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.Response of camels to intradermal inoculation with smallpox and camelpox viruses.Effect of glycosylation inhibitors on the release of enveloped vaccinia virus.Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus.Adsorption and penetration of enveloped and naked vaccinia virus particles.Polypeptide composition of extracellular enveloped vaccinia virus.The antigenicity and immunogenicity of the intracellular and extracellular forms of vaccinia virus. I: The production of high-titre vaccinia extracellular virus and its antigenicity after inactivation.A comparison of the antigens present on the surface of virus released artificially from chick cells infected with vaccinia virus, and cowpox virus and its white pock mutantExperimental study of the role of inactivated vaccine in two-step vaccination against smallpoxCharacterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccines.
P2860
Q24634729-3D58EC0B-C58C-4437-9575-580E2080F563Q33640531-A28538B6-7C4D-4977-8775-001A4FAE886DQ33782803-E1A90FE4-9647-4DAD-B7FA-2BCBD5288151Q33812636-A8431EC5-693A-4AB0-B44F-501FD1B2DBB9Q33907414-61DB59D4-3ECC-41F9-B4F5-BFDE95B6D446Q34478724-2838DB86-7D5D-4E88-B76D-C7CA8A294164Q34779016-9FC28FFE-EE09-4CD4-8515-F06420AFC2CFQ35241371-174CB5B5-E223-4E95-B1D0-D36AD02885CBQ35842621-E649C792-B965-4DFC-8913-4CDACCE42811Q35853542-82525AF5-82B9-4400-8DCE-6D75B7CB7C3CQ35861514-209168EC-480C-4D78-8789-FCF88F1F7A2DQ35884079-A4D06123-F989-4C0A-B06B-E9B997CC7828Q35948047-C15EE6CC-8112-4293-A2F5-73E108A108D3Q36103012-708F9B98-FBE6-4535-916C-F567B0B9A0F5Q36252256-6E5D3E7A-98B6-4157-9728-F483A73D2049Q36496450-FAC81D00-F901-4F48-8CED-AE5A3B266CB9Q36537978-E1565258-ECC5-41E7-A2FB-B89139704C29Q36651113-483685B7-0D41-4A8B-8A82-8FCEE532369EQ36687208-6C95E922-FC30-4D3E-9F6A-9EA5D1C910EDQ36698801-715CF92B-5749-424B-9444-106AE1CD61FDQ36820928-A67A4F41-EA82-49AB-B353-0668EF273019Q36845650-E781BCCE-386F-404F-9C81-278ACFEDED1EQ36863438-C0F34E64-2DB4-4422-8DAF-21EA8DE16285Q37066691-97C5F154-F36A-4CF5-AC44-ED64C5D7C653Q37511609-DA50BBE4-0BF4-4EC0-A60F-8368650883F9Q37909421-3D9A7665-5819-40E6-997B-E293EF0A1460Q39585406-A4DECAD1-6ECE-41A6-A6F9-1D18EE91716DQ39916149-B94138D6-79B4-430E-873E-6CF20D3E3B3BQ39924271-97029F2E-9CA7-41BD-9167-0818D167DA98Q40145028-0DA18DB2-C270-4621-9DAB-C8095ADC25ABQ40623481-63FB8BDD-8189-41B6-819F-580FF1370174Q40626374-533E728E-78CC-40A7-A7F9-1ACD9D78E2ABQ40626379-D8D05366-1633-4F6B-A3FA-2533540BB271Q41955979-7508322D-3D9E-4240-93E8-645EEB93C32DQ42036461-6B52AF64-436E-4FC8-B588-32CDA870ECB4Q42072073-DB160EB0-D858-45A2-82B4-AEA620621200Q42633733-4BC920EB-A5A4-4F84-A80C-0F1894366BAB
P2860
Inactivated smallpox vaccine: immunogenicity of inactivated intracellular and extracellular vaccinia virus.
description
1971 nî lūn-bûn
@nan
1971年の論文
@ja
1971年学术文章
@wuu
1971年学术文章
@zh
1971年学术文章
@zh-cn
1971年学术文章
@zh-hans
1971年学术文章
@zh-my
1971年学术文章
@zh-sg
1971年學術文章
@yue
1971年學術文章
@zh-hant
name
Inactivated smallpox vaccine: ...... extracellular vaccinia virus.
@en
Inactivated smallpox vaccine: ...... extracellular vaccinia virus.
@nl
type
label
Inactivated smallpox vaccine: ...... extracellular vaccinia virus.
@en
Inactivated smallpox vaccine: ...... extracellular vaccinia virus.
@nl
prefLabel
Inactivated smallpox vaccine: ...... extracellular vaccinia virus.
@en
Inactivated smallpox vaccine: ...... extracellular vaccinia virus.
@nl
P1476
Inactivated smallpox vaccine: ...... extracellular vaccinia virus.
@en
P2093
P356
10.1099/0022-1317-13-1-19
P407
P577
1971-10-01T00:00:00Z